Assessment of human abuse potential of an unflavored, sucralose-sweetened electronic cigarette in combustible cigarette smokers.

IF 2.4 3区 医学 Q3 PHARMACOLOGY & PHARMACY Experimental and clinical psychopharmacology Pub Date : 2024-10-01 Epub Date: 2024-05-30 DOI:10.1037/pha0000720
Sarah F Maloney, Cosima Hoetger, Rose S Bono, Rebecca Lester Scholtes, Madison Combs, Nareg Karaoghlanian, Thokozeni Lipato, Alison Breland, Thomas Eissenberg
{"title":"Assessment of human abuse potential of an unflavored, sucralose-sweetened electronic cigarette in combustible cigarette smokers.","authors":"Sarah F Maloney, Cosima Hoetger, Rose S Bono, Rebecca Lester Scholtes, Madison Combs, Nareg Karaoghlanian, Thokozeni Lipato, Alison Breland, Thomas Eissenberg","doi":"10.1037/pha0000720","DOIUrl":null,"url":null,"abstract":"<p><p>Despite the popularity of electronic cigarettes (ECIGs), limited research has examined the role of sweeteners, independent of other flavors, in shaping ECIG human abuse potential (HAP). This study examined the effects of sucralose and nicotine in unflavored ECIG liquid solutions to provide a basic understanding of the effects of sweeteners on ECIG HAP compared to combustible cigarettes. Individuals who smoked cigarettes daily (<i>N</i> = 14) completed five within-subject, Latin-square ordered study sessions that differed by product used: (a) own-brand combustible cigarettes (OB), (b) 0 mg/mL nicotine, unsweetened liquid, (c) 0 mg/mL nicotine, sucralose-sweetened liquid, (d) 15 mg/mL nicotine, unsweetened liquid, and (e) 15 mg/mL nicotine, sucralose-sweetened liquid. Participants completed subjective questionnaires and behavioral tasks following a 10-puff directed use bout during which puff topography was measured, and blood was sampled for later measurement of plasma nicotine concentration. On average, the OB condition had a greater increase in plasma nicotine concentration and produced more pronounced subjective effects compared to the ECIG conditions. The 15 mg/mL nicotine ECIGs delivered significantly more nicotine and produced greater drug effects and reductions in tobacco abstinence symptoms than the 0 mg/mL nicotine ECIGs. Sucralose-containing solutions increased ECIG product appeal, puff duration, and puff volume during the 10-puff directed bout. Findings revealed greater HAP for OB cigarettes relative to all ECIGs tested and suggest that adding sucralose and nicotine elevates ECIG HAP via different mechanisms; sucralose appears to influence HAP through product appeal, while nicotine influences HAP through drug effects and tobacco/nicotine abstinence symptom suppression. (PsycInfo Database Record (c) 2024 APA, all rights reserved).</p>","PeriodicalId":12089,"journal":{"name":"Experimental and clinical psychopharmacology","volume":null,"pages":null},"PeriodicalIF":2.4000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Experimental and clinical psychopharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1037/pha0000720","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/5/30 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Despite the popularity of electronic cigarettes (ECIGs), limited research has examined the role of sweeteners, independent of other flavors, in shaping ECIG human abuse potential (HAP). This study examined the effects of sucralose and nicotine in unflavored ECIG liquid solutions to provide a basic understanding of the effects of sweeteners on ECIG HAP compared to combustible cigarettes. Individuals who smoked cigarettes daily (N = 14) completed five within-subject, Latin-square ordered study sessions that differed by product used: (a) own-brand combustible cigarettes (OB), (b) 0 mg/mL nicotine, unsweetened liquid, (c) 0 mg/mL nicotine, sucralose-sweetened liquid, (d) 15 mg/mL nicotine, unsweetened liquid, and (e) 15 mg/mL nicotine, sucralose-sweetened liquid. Participants completed subjective questionnaires and behavioral tasks following a 10-puff directed use bout during which puff topography was measured, and blood was sampled for later measurement of plasma nicotine concentration. On average, the OB condition had a greater increase in plasma nicotine concentration and produced more pronounced subjective effects compared to the ECIG conditions. The 15 mg/mL nicotine ECIGs delivered significantly more nicotine and produced greater drug effects and reductions in tobacco abstinence symptoms than the 0 mg/mL nicotine ECIGs. Sucralose-containing solutions increased ECIG product appeal, puff duration, and puff volume during the 10-puff directed bout. Findings revealed greater HAP for OB cigarettes relative to all ECIGs tested and suggest that adding sucralose and nicotine elevates ECIG HAP via different mechanisms; sucralose appears to influence HAP through product appeal, while nicotine influences HAP through drug effects and tobacco/nicotine abstinence symptom suppression. (PsycInfo Database Record (c) 2024 APA, all rights reserved).

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
评估一种无味、含三氯蔗糖的电子香烟在可燃卷烟吸烟者中的人体滥用潜力。
尽管电子香烟(ECIG)很受欢迎,但对甜味剂(与其他口味无关)在影响 ECIG 人体滥用潜能(HAP)方面作用的研究却很有限。本研究考察了三氯蔗糖和尼古丁在无味 ECIG 液体溶液中的作用,以便基本了解与可燃卷烟相比,甜味剂对 ECIG HAP 的影响。每天吸烟的人(N = 14)完成了五次受试者内拉丁方阵排序研究,不同的产品使用了不同的甜味剂:(a) 自有品牌可燃卷烟(OB),(b) 0 毫克/毫升尼古丁、不加甜味剂的液体,(c) 0 毫克/毫升尼古丁、加三氯蔗糖甜味剂的液体,(d) 15 毫克/毫升尼古丁、不加甜味剂的液体,以及 (e) 15 毫克/毫升尼古丁、加三氯蔗糖甜味剂的液体。参与者在进行 10 次直接吸食后完成主观问卷和行为任务,在此期间测量吸食地形,并抽取血液样本用于随后的血浆尼古丁浓度测量。平均而言,与 ECIG 条件相比,OB 条件下的血浆尼古丁浓度增幅更大,产生的主观效果也更明显。与0毫克/毫升尼古丁的ECIG相比,15毫克/毫升尼古丁的ECIG释放的尼古丁明显更多,产生的药物效应和戒烟症状的减轻也更明显。含三氯蔗糖的溶液增加了ECIG产品的吸引力、吸食时间以及10次定向吸食的吸食量。研究结果表明,相对于所有测试的ECIG,OB香烟的HAP更大,并表明添加三氯蔗糖和尼古丁会通过不同的机制提高ECIG的HAP;三氯蔗糖似乎通过产品吸引力影响HAP,而尼古丁则通过药物效应和烟草/尼古丁戒断症状抑制影响HAP。(PsycInfo 数据库记录 (c) 2024 APA,保留所有权利)。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
4.20
自引率
8.70%
发文量
164
审稿时长
6-12 weeks
期刊介绍: Experimental and Clinical Psychopharmacology publishes advances in translational and interdisciplinary research on psychopharmacology, broadly defined, and/or substance abuse.
期刊最新文献
Evaluating the human abuse potential of concurrent use of electronic cigarettes and low nicotine cigarettes among adults who smoke. Residual next-day effects of alprazolam on psychomotor performance and simulated driving in healthy normal adults. Efficacy and safety of balovaptan for posttraumatic stress disorder: A randomized, placebo-controlled trial. A behavioral choice analysis of the role of life events during early nonabstinent natural recovery from alcohol use disorder. An experimental investigation into the impact of acute stress on alcohol craving.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1